(NEW YORK) -- Eli Lilly will cut the price of its most commonly prescribed insulin products by 70% and expand a program that caps patient costs at $35 per month, the company said on Wednesday."While the current healthcare system provides access to insulin for... Read More.
(NEW YORK) -- Nearly 30% of Americans living with diabetes who are uninsured may ration their insulin to save money, according to a new study.Researchers at Harvard Medical School, the City University of New York's Hunter College and consumer advocacy organization Public Citizen determined... Read More.
(NEW YORK) -- A 10-year-old boy is on a mission to make life easier for the 37.7 million Americans who suffer from diabetes.Jameson Wardle was 5 years old when he was diagnosed with type 1 diabetes, a chronic disease in which the insulin-making cells... Read More.
(WASHINGTON) -- Nearly uniform Republican opposition in the Senate on Sunday stripped a proposed cap on insulin prices in private insurance from Democrats' party-line climate, health and tax bill.Democrats had sought to overrule a decision from the Senate rules official, the parliamentarian, that a... Read More.
(WASHINGTON) -- Congress could soon send to the president's desk a bill that would cap the cost of the lifesaving drug insulin at $35 per month -- a move that could significantly reduce and rein in out-of-pocket drug costs for millions of Americans with... Read More.
(NEW YORK) -- Walmart announced it is launching its own private brand of insulin, which the big box chain says will save customers with diabetes up to 75% on the lifesaving drug.Walmart's ReliOn brand will sell private label NovoLog short-acting insulin that is manufactured... Read More.